Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
88.19
+0.96 (+1.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
54
55
Next >
Amended European Deal For BioNTech-Pfizer's Covid-19 Vaccines Allows Reduced Purchases
May 26, 2023
Via
Benzinga
Why Pfizer Stock Slipped by 2% Today
May 25, 2023
The market wasn't impressed by the company's latest drug approval, plus an analyst cut her price target on the shares.
Via
The Motley Fool
BioNTech's Ready-to-Use Single Dose Vaccine, the Perfect Counterattack to China's Rising XBB1.5 Cases
May 25, 2023
In an annual general meeting, BioNTech SE's (NASDAQ: BNTX) CEO and co-founder Ugur Sahin told shareholders the company is working on COVID-19 vaccines targeting XBB.1.5 strains in line with...
Via
Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
May 24, 2023
(Wednesday market open) Investors seeking distraction from the ticking debt ceiling countdown clock get some this afternoon in the form of Federal Reserve meeting minutes and Nvidia (NASDAQ: NVDA)...
Via
Benzinga
Why Novavax, Pfizer And BioNTech Shares Are Rising Today
May 24, 2023
Shares of vaccine makers Novavax Inc (NASDAQ: NVAX), Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) a
Via
Benzinga
What To Know About Redburn Partners's Upgrade of BioNTech
May 17, 2023
Via
Benzinga
A Look Into Healthcare Sector Value Stocks
May 15, 2023
Via
Benzinga
Expert Ratings for BioNTech
May 09, 2023
Via
Benzinga
BioNTech Se (BNTX) Q1 2023 Earnings Call Transcript
May 08, 2023
BNTX earnings call for the period ending March 31, 2023.
Via
The Motley Fool
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
May 23, 2023
Both are experiencing a bit of a hangover from declining COVID-19-related sales.
Via
The Motley Fool
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
May 19, 2023
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the
Via
Benzinga
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
May 18, 2023
Needham raised the price target for Dynatrace, Inc. (NYSE: DT) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares gained 1.9% to $47.95 in pre-market trading.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2023
May 17, 2023
Via
Benzinga
A Look Into BioNTech Inc's Price Over Earnings
May 08, 2023
Via
Benzinga
Earnings Preview For BioNTech
May 05, 2023
Via
Benzinga
How To Attend BioNTech Q1 2023 Earnings Conference Call
April 27, 2023
Via
Benzinga
Why Matinas BioPharma Stock Is Sinking Today
May 11, 2023
BioNTech SE (NASDAQ: BNTX) and Matinas BioPharma Holdings Inc (NYSE: MTNB) have ended an mRNA-based collaboration.
Via
Benzinga
Woodstock For Capitalists
May 08, 2023
Good Morning Everyone! Regional bank PacWest is up 34% in pre-market after being up 81% Friday. They slashed their dividend to conserve capital. With a 19% short interest on the stock, there is...
Via
Benzinga
WHO Ends Global Emergency Status for COVID-19, Virgin Galactic Plans To Launch Space Tourism In Q2, Berkshire Hathaway Has No Intentions To Take Control Of Occidental Petroleum: Today's Top Stories
May 08, 2023
Benzinga
Via
Benzinga
BioNTech Stock Jumps As Covid Vaccine Sales, Profits Beat Expectations
May 08, 2023
The launch of an updated booster could increase demand.
Via
Investor's Business Daily
Buy This Pharma Powerhouse With A 4% Yield
April 21, 2023
Imagine a company whose stock hit an all-time in December 2021 after soaring 50% that year. And that company’s sales doubled in the two years leading up to 2022. And its operating profits quadrupled.
Via
Talk Markets
Despite Continuous Dip In Covid-19 Vaccine Sales, BioNTech Manages To Post Q1 Profit, Reaffirms Guidance
May 08, 2023
BioNTech SE (NASDAQ: BNTX) reported Q1 FY23 revenues of €1.28 billion, down from €6.37 billion a year ago, mainly due to lower commercial revenues from the supply and sales of the
Via
Benzinga
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
May 08, 2023
The World Health Organization ended the global emergency
Via
Benzinga
US Stocks Set For Mixed Start This Week On Inflation, Debt Ceiling Worries — But Analyst Sees A 'Turning Point'
May 08, 2023
Caution returned to Wall Street as indicated by the index futures, which traded narrowly mixed early Monday.
Via
Benzinga
The 7 Best Bargain Stocks to Buy for May 2023
May 04, 2023
With inflation crimping everyone’s wallet, these best bargain stocks to buy can make your dollars stretch significantly.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
May 04, 2023
Via
Benzinga
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
May 01, 2023
Benzinga
Via
Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
May 01, 2023
The European Union bloc is reportedly negotiating an amended deal with Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) for around 70 million COVID-19 vaccine doses, despite the European public...
Via
Benzinga
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
April 28, 2023
Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies.
Via
Investor's Business Daily
Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?
April 20, 2023
The company is facing a litigation headwind and continued competition.
Via
Investor's Business Daily
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
54
55
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.